@RAFUH
btw I presume the plan itself is good progress?
Overall, I’m going to say no - because it sounds good, but really isn’t going to help a lot of folks. But I haven’t seen the details published so educated guess here.
Best I can tell, this only effects plans that have a coinsurance cost instead of a copy for insulin. Coinsurance means you pay a % of the total cost of the medication as opposed to the set dollar amount of a copy. I’ve seen coinsurance be 15-65%. For those plans, $35/ month will generally be cheaper and consistent to help with budgeting each month at the pharmacy.
However, those plans tend to have lower premiums which is why folks pick them. The article you linked says premiums will go up a “$1 or 2” per month to which I say horse hockey...or maybe it is the first year, but It will jump up next year when the costs roll in and Trump is no longer trying to woo the elderly back in an election year.
Also, this does nothing about deductibles which for Part D are around $400-450. And since a months supply of a single low dose of insulin is minimally -$200, a patient still has a high up front cost to get their insulin in January of each year. The $35 copay would not kick in until the full deductible is met and many folks don’t have the savings to cover it.
Manufacturers could easily reduce the cost of insulin and this would not be an issue at all.
Or we could even contract government pricing, but socialism or something.